Author: admin

Ascites Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, Prevalence, Therapies, Clinical Trials and Companies by DelveInsight

“Ascites Treatment Market”
Ascites Companies are Grifols Therapeutics LLC, Sanofi, Regeneron Pharmaceuticals, Sequana Medical N.V, Protgen Ltd, Healthgen Biotechnology Corp, Sichuan Clover Biopharmaceuticals Inc, Movetis, BioVie Inc., Ocelot Bio Inc, Novartis, and others.

(Albany, USA)   DelveInsight’s “Ascites Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of the Ascites, historical and forecasted epidemiology as well as the Ascites market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Ascites Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Ascites Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.

 

Unlock detailed insights into the Ascites Market by downloading the comprehensive report from DelveInsight @ Ascites Treatment Market Size

 

Key Takeaways from the Ascites Market Report

  • In September 2024:- Versantis AG- A Phase 2a, Open-label, Randomized, Controlled, Multi-Center Study to Assess the Efficacy, Safety and Tolerability of VS-01 on Top of Standard of Care (SOC), Compared to SOC Alone, in Adult Patients With Acute-on-Chronic Liver Failure (ACLF) Grades 1 and 2 and Ascites.
  • It is estimated that the Ascites treatment market will experience significant changes during the forecast period of 2024–2034, owing to the launch of new therapies that are in clinical development.
  • DelveInsight analysis indicates that in 2023, the US had approximately 153 thousand cases of Ascites due to Cirrhosis, accounting for the largest share in the 7MM.
  • DelveInsight’s analysis revealed that in Japan during 2023, there were 5,355 instances of Grade I ascites attributed to cirrhosis. Additionally, more severe cases of Grade II and III ascites were recorded at 24,394 cases each in the same year.
  • The leading Ascites Companies such as Grifols Therapeutics LLC, Sanofi, Regeneron Pharmaceuticals, Sequana Medical N.V, Protgen Ltd, Healthgen Biotechnology Corp, Sichuan Clover Biopharmaceuticals Inc, Movetis, BioVie Inc., Ocelot Bio Inc, Novartis, and others.
  • Promising Ascites Therapies such as Recombinant Human Serum Albumin, M701, paracentesis, OrsHSA, VS-01, Ambrisentan, Terlipressin, and others.

 

Gain a competitive edge in the Ascites Market by exploring our in-depth analysis. Visit our website to access the full report and make informed strategic decisions @ Ascites Treatment Drugs

 

Ascites Epidemiology Segmentation in the 7MM

  • Number of Ascites Cases by Malignancies
  • Number of Ascites Cases due to Cirrhosis
  • Severity-specific Cases of Ascites due to Cirrhosis
  • Refractory Ascites Patients with Cirrhosis

 

Ascites Treatment Market Landscape

The treatment landscape of ascites due to cirrhosis include diuretics, paracentesis, insertion of a transjugular intrahepatic portosystemic shunt (TIPS), as well as managing complications to ascites such as spontaneous bacterial peritonitis (SBP). Mild and moderate ascites due to liver cirrhosis can be treated with dietary sodium restriction, treatment of the underlying disorder, fluid restriction, use of diuretics, and use of therapeutic paracentesis.

 

Discover key developments and opportunities in the Ascites Market. Click here to learn more from DelveInsight’s latest report @ Ascites Market Size

 

Ascites Drugs Market

The Ascites market for drugs targeting ascites is notably constrained. While certain treatments provide symptomatic relief, there is a significant lack of approved drugs addressing the condition’s underlying causes. This scarcity of targeted treatments reflects a major challenge in effectively managing the diverse manifestations of ascites, indicating a substantial need for innovative solutions and advancements in drug development for more comprehensive care.

 

Ascites Emerging Drugs Profile

  • OCE-205: Ocelot Bio
  • BIV201 (terlipressin): Biovie

 

Download DelveInsight’s Ascites Market report today and stay ahead in this rapidly evolving field. @ Ascites Clinical Trials

 

Scope of the Ascites Market Report

  • Coverage- 7MM
  • Ascites Companies- as Grifols Therapeutics LLC, Sanofi, Regeneron Pharmaceuticals, Sequana Medical N.V, Protgen Ltd, Healthgen Biotechnology Corp, Sichuan Clover Biopharmaceuticals Inc, Movetis, BioVie Inc., Ocelot Bio Inc, Novartis, and others.
  • Ascites Therapies- Recombinant Human Serum Albumin, M701, paracentesis, OrsHSA, VS-01, Ambrisentan, Terlipressin, and others.
  • Ascites Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
  • Ascites Unmet Needs, KOL’s views, Analyst’s views, Ascites Market Access and Reimbursement

 

Download the report to understand which factors are driving Ascites Market Trends @ Ascites Market Trends

 

Table of Content

1. Key Insights

2. Report Introduction

3. Executive Summary

4. Ascites Market Overview at a Glance

5 Key Events

6 Epidemiology and Market Forecast Methodology

7 Disease Background and Overview

8 Epidemiology and Patient Population

9 Patient Journey

10 Emerging Therapies

11 Ascites: Seven Major Market Analysis

12 Unmet Needs

13 SWOT Analysis

14 KOL Views

15 Market Access and Reimbursement

16 Appendix

17 DelveInsight Capabilities

18 Disclaimer

19 About DelveInsight

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/primary-research-services

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Ascites Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, Prevalence, Therapies, Clinical Trials and Companies by DelveInsight

PD-1 Non-Small Cell Lung Cancer Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, Prevalence, Therapies, Clinical Trials and Companies by DelveInsight

“PD-1 Non-Small Cell Lung Cancer Treatment Market”
PD-1 Non-Small Cell Lung Cancer Companies are Merck, Bristol-Myers Squibb/Ono Pharmaceutical, Genentech/ Hoffmann-La Roche, Regeneron/Sanofi, BeiGene, Genor Biopharma, Shandong Boan Biotechnology, Pfizer, AstraZeneca, Lepu Biopharma, GlaxoSmithKline, Incyte Corporation, Akeso Biopharma, Arcus Biosciences, Summit Therapeutics, Seagen, and others.

(Albany, USA) DelveInsight’s “PD-1 Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the PD-1 Non-Small Cell Lung Cancer, historical and forecasted epidemiology as well as the PD-1 Non-Small Cell Lung Cancer market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

To Know in detail about the PD-1 Non-Small Cell Lung Cancer market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; PD-1 Non-Small Cell Lung Cancer Market Forecast

 

Some of the key facts of the PD-1 Non-Small Cell Lung Cancer Market Report: 

  • The PD-1 Non-Small Cell Lung Cancer market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
  • In April 2024, BeiGene announced that the European Commission (EC) has granted approval for TIZVENI (tislelizumab) as a treatment for NSCLC, covering three indications, including both first- and second-line use.
  • The PD-(L)1 mNSCLC market size in the US was estimated at approximately USD 6.2 billion in 2023 and is projected to grow further, driven by the introduction of new therapies and expanded indications for existing treatments.
  • In 2023, the total number of new non-small cell lung cancer (NSCLC) cases in the 7MM was approximately 524,000, and this number is expected to rise throughout the forecast period.
  • In 2023, the incidence of non-small cell lung cancer (NSCLC) cases in the United States was approximately 56% in males and around 44% in females.
  • In 2023, the total number of NSCLC cases in the EU4 and the UK was estimated at around 203,220, with Germany recording the highest number of cases among these countries.
  • The PD-(L)1 biomarker testing rate in the US is approximately 85%. In Japan, the testing rate is higher compared to the EU4 countries and the UK.
  • In 2023, the total number of PD-(L)1 NSCLC cases in the US was approximately 101,300.
  • Key PD-1 Non-Small Cell Lung Cancer Companies: Merck, Bristol-Myers Squibb/Ono Pharmaceutical, Genentech/ Hoffmann-La Roche, Regeneron/Sanofi, BeiGene, Genor Biopharma, Shandong Boan Biotechnology, Pfizer, AstraZeneca, Lepu Biopharma, GlaxoSmithKline, Incyte Corporation, Akeso Biopharma, Arcus Biosciences, Summit Therapeutics, Seagen, and others
  • Key PD-1 Non-Small Cell Lung Cancer Therapies: KEYTRUDA (pembrolizumab), OPDIVO (nivolumab), TECENTRIQ (atezolizumab), LIBTAYO (cemiplimab-rwlc), TIZVENI (tislelizumab), GB226, BA-1104, PF-06801591, AZD2936, HX008, Dostarlimab, INCMGA00012, AK-112, Zimberelimab, Ivonescimab, Sasanlimab, Rilvegostomig, SGN-PDL1V, and others
  • The PD-1 Non-Small Cell Lung Cancer market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage PD-1 Non-Small Cell Lung Cancer pipeline products will significantly revolutionize the PD-1 Non-Small Cell Lung Cancer market dynamics.

 

PD-1 Non-Small Cell Lung Cancer Overview

PD-1 Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all lung cancer cases. It is a category of epithelial lung cancer that includes several subtypes with similar treatment approaches and prognoses.

 

Get a Free sample for the PD-1 Non-Small Cell Lung Cancer Market Report: https://www.delveinsight.com/report-store/pd-1-non-small-cell-lung-cancer-market

 

PD-1 Non-Small Cell Lung Cancer Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

PD-1 Non-Small Cell Lung Cancer Epidemiology Segmentation:

The PD-1 Non-Small Cell Lung Cancer market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

  • Total Prevalence of PD-1 Non-Small Cell Lung Cancer
  • Prevalent Cases of PD-1 Non-Small Cell Lung Cancer by severity
  • Gender-specific Prevalence of PD-1 Non-Small Cell Lung Cancer
  • Diagnosed Cases of Episodic and Chronic PD-1 Non-Small Cell Lung Cancer

 

Download the report to understand which factors are driving PD-1 Non-Small Cell Lung Cancer epidemiology trends @ PD-1 Non-Small Cell Lung Cancer Epidemiology Forecast

 

PD-1 Non-Small Cell Lung Cancer Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the PD-1 Non-Small Cell Lung Cancer market or expected to get launched during the study period. The analysis covers PD-1 Non-Small Cell Lung Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the PD-1 Non-Small Cell Lung Cancer Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

PD-1 Non-Small Cell Lung Cancer Therapies and Key Companies

  • KEYTRUDA (pembrolizumab): Merck
  • OPDIVO (nivolumab): Bristol-Myers Squibb/Ono Pharmaceutical
  • TECENTRIQ (atezolizumab): Genentech/ Hoffmann-La Roche
  • LIBTAYO (cemiplimab-rwlc): Regeneron/Sanofi
  • TIZVENI (tislelizumab): BeiGene
  • GB226: Genor Biopharma
  • BA-1104: Shandong Boan Biotechnology
  • PF-06801591: Pfizer
  • AZD2936: AstraZeneca
  • HX008: Lepu Biopharma
  • Dostarlimab: GlaxoSmithKline
  • INCMGA00012: Incyte Corporation
  • AK-112: Akeso Biopharma
  • Zimberelimab: Arcus Biosciences
  • Ivonescimab: Summit Therapeutics
  • Sasanlimab: Pfizer
  • Rilvegostomig: AstraZeneca
  • SGN-PDL1V: Seagen

 

Discover more about therapies set to grab major PD-1 Non-Small Cell Lung Cancer market share @ PD-1 Non-Small Cell Lung Cancer Medication

 

PD-1 Non-Small Cell Lung Cancer Market Drivers

  • Premium-price targeted agents with better clinical profile and expansion of therapies in the first-line expected to drive the growth of NSCLC market
  • The development of therapies targeting specific mutations are expected to dominate the upcoming market

 

PD-1 Non-Small Cell Lung Cancer Market Barriers

  • Potential for premium pricing of emerging therapies by showing an edge over current therapies Uptake of potential emerging therapies with better clinical profile, specificity towards mutations occurs in NSCLC and therapies to overcome resistance expected to be fast

 

Scope of the PD-1 Non-Small Cell Lung Cancer Market Report

  • Study Period: 2020–2034
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key PD-1 Non-Small Cell Lung Cancer Companies: Merck, Bristol-Myers Squibb/Ono Pharmaceutical, Genentech/ Hoffmann-La Roche, Regeneron/Sanofi, BeiGene, Genor Biopharma, Shandong Boan Biotechnology, Pfizer, AstraZeneca, Lepu Biopharma, GlaxoSmithKline, Incyte Corporation, Akeso Biopharma, Arcus Biosciences, Summit Therapeutics, Seagen, and others
  • Key PD-1 Non-Small Cell Lung Cancer Therapies: KEYTRUDA (pembrolizumab), OPDIVO (nivolumab), TECENTRIQ (atezolizumab), LIBTAYO (cemiplimab-rwlc), TIZVENI (tislelizumab), GB226, BA-1104, PF-06801591, AZD2936, HX008, Dostarlimab, INCMGA00012, AK-112, Zimberelimab, Ivonescimab, Sasanlimab, Rilvegostomig, SGN-PDL1V, and others
  • PD-1 Non-Small Cell Lung Cancer Therapeutic Assessment: PD-1 Non-Small Cell Lung Cancer current marketed and PD-1 Non-Small Cell Lung Cancer emerging therapies
  • PD-1 Non-Small Cell Lung Cancer Market Dynamics: PD-1 Non-Small Cell Lung Cancer market drivers and PD-1 Non-Small Cell Lung Cancer market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • PD-1 Non-Small Cell Lung Cancer Unmet Needs, KOL’s views, Analyst’s views, PD-1 Non-Small Cell Lung Cancer Market Access and Reimbursement 

 

To know more about PD-1 Non-Small Cell Lung Cancer companies working in the treatment market, visit @ PD-1 Non-Small Cell Lung Cancer Clinical Trials and Therapeutic Assessment

 

Table of Contents 

1. PD-1 Non-Small Cell Lung Cancer Market Report Introduction

2. Executive Summary for PD-1 Non-Small Cell Lung Cancer

3. SWOT analysis of PD-1 Non-Small Cell Lung Cancer

4. PD-1 Non-Small Cell Lung Cancer Patient Share (%) Overview at a Glance

5. PD-1 Non-Small Cell Lung Cancer Market Overview at a Glance

6. PD-1 Non-Small Cell Lung Cancer Disease Background and Overview

7. PD-1 Non-Small Cell Lung Cancer Epidemiology and Patient Population

8. Country-Specific Patient Population of PD-1 Non-Small Cell Lung Cancer 

9. PD-1 Non-Small Cell Lung Cancer Current Treatment and Medical Practices

10. PD-1 Non-Small Cell Lung Cancer Unmet Needs

11. PD-1 Non-Small Cell Lung Cancer Emerging Therapies

12. PD-1 Non-Small Cell Lung Cancer Market Outlook

13. Country-Wise PD-1 Non-Small Cell Lung Cancer Market Analysis (2020–2034)

14. PD-1 Non-Small Cell Lung Cancer Market Access and Reimbursement of Therapies

15. PD-1 Non-Small Cell Lung Cancer Market Drivers

16. PD-1 Non-Small Cell Lung Cancer Market Barriers

17.  PD-1 Non-Small Cell Lung Cancer Appendix

18. PD-1 Non-Small Cell Lung Cancer Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/conference-coverage-services

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: PD-1 Non-Small Cell Lung Cancer Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, Prevalence, Therapies, Clinical Trials and Companies by DelveInsight

The Farber Law Firm Launches New Initiative to Assist Accident Victims in Coral Gables

The Farber Law Firm Launches New Initiative to Assist Accident Victims in Coral Gables
The Farber Law Firm, a prominent legal service provider in Coral Gables, has announced the launch of a new initiative to assist accident victims in navigating the complexities of personal injury claims. With extensive experience in handling a wide range of cases, the firm is committed to providing tailored support to individuals affected by accidents.

This initiative responds to the growing need for compassionate legal assistance following unexpected incidents. Many individuals face overwhelming challenges when dealing with insurance companies and legal processes after an accident, often exacerbated by physical and emotional stress. The Farber Law Firm aims to ease this burden by offering accessible resources and personalized legal guidance to victims and their families.

As part of this initiative, the firm will host a series of free informational seminars designed to educate the public about their rights and options after an accident. These seminars will cover crucial topics, including understanding the claims process, negotiating with insurance providers, and securing fair compensation for medical expenses and lost wages.

The firm’s approach underscores the importance of having an accident attorney Coral Gables who is well-versed in the intricacies of personal injury law. By providing clear, concise information and addressing common misconceptions, The Farber Law Firm hopes to empower accident victims to make informed decisions regarding their legal rights.

In addition to educational outreach, The Farber Law Firm is dedicated to offering supportive legal representation throughout the claims process. With a strong focus on client advocacy, the firm strives to ensure that every client receives the attention and care needed to navigate their unique situation effectively.

For those seeking assistance, the firm emphasizes the importance of consulting with a knowledgeable insurance attorney Coral Gables, who can provide guidance tailored to individual circumstances. The Farber Law Firm remains committed to advocating for the rights of accident victims, reinforcing its dedication to the community through this vital initiative.

For more information about the initiative or to register for an upcoming seminar, please visit The Farber Law Firm’s website.

Media Contact
Company Name: The Farber Law Firm
Contact Person: David Farber
Email: Send Email
Phone: 305-774-0134
Address:2199 Ponce de Leon #301
City: Coral Gables
State: Florida
Country: United States
Website: http://www.thefarberlawfirm.com/

Lantana Recovery Expands Outreach Services in Greenville, SC

Lantana Recovery Expands Outreach Services in Greenville, SC
Lantana Recovery is pleased to announce the expansion of its outreach services in Greenville, SC. This initiative aims to support individuals seeking recovery options in the local community. As an outreach office, Lantana Recovery connects individuals with resources and programs tailored to their unique needs.

The Greenville location serves as a vital link between individuals seeking assistance and the comprehensive outpatient rehab Greenville SC services available at Lantana Recovery’s Charleston facility. While the Greenville office does not provide inpatient rehab services, it plays a crucial role in guiding clients toward appropriate resources and referrals.

Lantana Recovery’s outreach initiative focuses on education and community support. The team is dedicated to helping individuals understand their options for recovery, emphasizing the importance of connection and guidance during the process. Clients in Greenville can expect personalized assistance in navigating their recovery journey, with trained professionals available to answer questions and provide support.

For individuals seeking more intensive drug rehab Greenville SC services, Lantana Recovery’s Charleston facility remains the primary provider. The dedicated team at this location offers comprehensive treatment programs designed to address various needs. While the Greenville outreach office does not offer detox or inpatient rehab services, it is committed to referring clients to trusted providers for these essential services.

In summary, Lantana Recovery’s outreach office in Greenville, SC, serves as an essential resource for individuals seeking support in their recovery journey. By extending services to Columbia, SC, and focusing on community education, Lantana Recovery reinforces its commitment to helping individuals find the right path toward recovery. For more information on Lantana Recovery’s outreach services, please visit the website or contact the Greenville office directly.

The dedicated team at Lantana Recovery looks forward to continuing its mission of supporting those in need through accessible and compassionate outreach services in the region.

Media Contact
Company Name: Lantana Recovery (Greenville)
Contact Person: Amanda Cook
Email: Send Email
Phone: (864) 532-5082
Address:301 Augusta St Unit 101
City: Greenville
State: SC 29601
Country: United States
Website: https://lantanarecovery.com/addiction-services-near-me/outpatient-rehab-greenville-south-carolina/

Denver’s Premier Luxury Lifestyle and Home Management Firm, Griffin Concierge, Expands to Scottsdale, Arizona

Denver’s Premier Luxury Lifestyle and Home Management Firm, Griffin Concierge, Expands to Scottsdale, Arizona

“After years of building trust and delivering top-tier home management services in Denver, we are thrilled to bring the Griffin Concierge experience to Scottsdale,” said Jim Anderson, Owner of Griffin Concierge.
Griffin Concierge, luxury lifestyle and home management solutions leader, expands from Denver, Colorado, to Scottsdale, Arizona, bringing top-tier property management, lifestyle solutions, and event coordination to discerning homeowners. Founded by Jim Anderson, Griffin Concierge offers high-end, personalized, proactive property oversight, enhanced living experience with exceptional care and detail. Now Scottsdale homeowners can enjoy the same Forbes-style service Denver clients know and trust.

 

 

Griffin Concierge, a premier luxury lifestyle and home solutions company well-established in Denver, Colorado, is excited to announce its expansion into Scottsdale, Arizona. With a reputation for delivering exceptional, personalized lifestyle management services, Griffin Concierge now brings its expertise to discerning homeowners in Scottsdale, ensuring that every aspect of their lifestyle is meticulously managed.

Having set a Forbes-style standard in Denver for proactive, high-quality service, Griffin Concierge continues to excel in providing seamless lifestyle management solutions that enrich the lives of its clients. The company’s expansion into the Scottsdale market ensures that luxury homeowners in Arizona will now benefit from Griffin Concierge’s unparalleled attention to detail, privacy, and efficiency.

“After years of building trust and delivering top-tier home management services in Denver, we are thrilled to bring the Griffin Concierge experience to Scottsdale,” said Jim Anderson, Owner of Griffin Concierge. “Scottsdale’s luxury homeowners can expect the same meticulous attention to detail and personalized care that has made our services so highly regarded in Denver. Our goal is to elevate the quality of life for our clients, allowing them to focus on what matters most.”

A New Standard in Luxury Lifestyle and Home Solutions

Griffin Concierge’s dedicated team offers comprehensive management for every aspect of luxury homes, from meticulous maintenance and security to bespoke lifestyle services, including event coordination and personalized care. Understanding that each homeowner’s lifestyle is unique, Griffin Concierge tailors its services to match the highest standards of elegance, efficiency, and discretion.

With its expansion into Scottsdale, Griffin Concierge remains committed to providing its Denver clients with the same level of care and expertise that has earned the company its stellar reputation.

About Griffin Concierge

Griffin Concierge is a full-service luxury lifestyle and home solutions management company serving prestigious clients in Scottsdale, Arizona, and Denver, Colorado. With a team of dedicated professionals, Griffin Concierge provides personalized, proactive services that anticipate client needs, ensuring that homes are managed with the highest level of care and attention. At Griffin Concierge, the goal is to provide an experience that enhances comfort, preserves privacy, and allows clients to focus on living their best lives.

FaceBook/Meta

LinkedIn

GoogleMaps

Media Contact
Company Name: Griffin Concierge
Contact Person: James Anderson
Email: Send Email
Phone: 602.290.2192
City: Denver
State: Colorado
Country: United States
Website: https://griffinconcierge.net/

CALM DOWN: The Mysterious Brand Turning Exclusivity into a Movement

CALM DOWN: The Mysterious Brand Turning Exclusivity into a Movement

CALM DOWN hat
CALM DOWN burst onto the scene as an enigmatic lifestyle brand, captivating audiences with its exclusivity and bold designs without initially selling a single product. The brand gained cultural traction through organic appearances in elite locales and on high-profile figures, creating a sense of mystery and demand.

In early 2024, a new and enigmatic brand quietly emerged, captivating global audiences without selling a single product. CALM DOWN, with its bold designs and cryptic branding, infiltrated the zeitgeist through organic appearances in exclusive locales like the Bahamas, Miami, and New York City. Before long, its logo and underlying coordinates were spotted on high-profile figures, including Miami-based DJ Purple, actor and host Terry Crews, and Olympic gold medalist Simone Biles.

Almost overnight, CALM DOWN became a symbol of exclusivity, mystery, and cultural relevance. Those seen wearing CALM DOWN gear were approached both in person and online by curious fans eager to learn how to obtain the elusive items. Stories began circulating of wearers being questioned at Union Square Cafe in Manhattan and even rumors of athletes offering game tickets in exchange for CALM DOWN merchandise.

Refusing to Sell, Before Donating: Building Demand Through Scarcity

For months, CALM DOWN refused to sell its products to the public, adding to its allure. While a select few quietly acquired items, there was no clear path to ownership. Even the brand’s first publicly available item—a signature CALM DOWN hat—wasn’t sold but donated to the Sean Loring Classic, benefiting the UC Health Foundation. The hat fetched an astonishing $4,200 at auction, purchased by an anonymous bidder rumored to be a prominent South Florida lawyer.

The First Drop: A Frenzy

On Black Friday 2024, CALM DOWN finally made its first foray into e-commerce, launching its signature hats in three variations: all-white, all-black, and a black-and-white combination. Priced at $149 each, the collection sold out in minutes. A surprise Cyber Monday restock briefly replenished inventory but was met with the same overwhelming demand. By the end of the week, all designs were sold out, with the all-black hat already being touted as a collector’s item.

Global Sightings, Secret Spotlights

CALM DOWN’s unconventional approach to marketing has only amplified its mystique. Stickers bearing its logo have appeared in unexpected locales, from lampposts in Kyoto to café walls in Bangkok. During Art Basel Miami, a Tesla Cybertruck wrapped in CALM DOWN’s logo cruised the streets, sparking conversation and speculation with its QR code-laden fenders. This bold yet enigmatic branding strategy has fueled the brand’s organic rise, leaving fans and influencers eagerly awaiting the next move.

A Movement, Not Just Merchandise

CALM DOWN represents more than just a product line—it’s a cultural touchpoint. Operating without traditional advertising, the brand thrives on scarcity, intrigue, and the power of word-of-mouth. Its Instagram account, @calmdownperiod, offers sparse yet tantalizing glimpses of unreleased gear, further fueling demand.

With a growing global following, CALM DOWN’s impact reaches beyond fashion. Fans speculate about what’s next—possible collaborations, new product lines, or even experiential events. Whatever the future holds, CALM DOWN has already cemented its status as a in modern branding, proving that mystery and patience can captivate even the most unbothered fashion connoisseurs.

About CALM DOWN

CALM DOWN is a lifestyle brand that defies conventions through exclusivity, bold design, and an enigmatic approach to marketing. From its global sightings to its record-breaking product launches, CALM DOWN has become a symbol of cultural relevance and modern luxury.

Media Contact
Company Name: CALM DOWN.
Contact Person: Kevin Saunders
Email: Send Email
City: Miami
State: Florida
Country: United States
Website: https://calmdownperiod.com

Wash Patrol Expands Renowned Dirt Defense Wash Programs to Commercial Customers

Wash Patrol Expands Renowned Dirt Defense Wash Programs to Commercial Customers

Commercial Power Washing & Steam Cleaning
America’s Leading Pressure Washing Service Enhances Offerings for Year-Round Property Maintenance

Wash Patrol, recognized as America’s first choice for residential pressure washing and commercial power washing services, is proud to announce the expansion of its acclaimed Dirt Defense Wash Programs to commercial customers. This strategic move aims to provide businesses with the same high-quality exterior maintenance that has made Wash Patrol a household name in residential services.

With a strong reputation for excellence in pressure washing, Wash Patrol has consistently delivered professional services that ensure properties remain pristine throughout the year. The introduction of the Dirt Defense Wash Programs for commercial properties marks a significant enhancement in the company’s service offerings, catering to the growing demand for reliable and efficient exterior maintenance solutions in the commercial sector.

The Dirt Defense Wash Programs are meticulously designed to address the unique needs of commercial properties, offering tailored solutions that guarantee optimal cleanliness and maintenance. These programs are set to revolutionize the way businesses approach property upkeep, providing them with a comprehensive plan that covers all aspects of exterior cleaning and maintenance.

“Our Dirt Defense Wash Programs have been a game-changer for residential clients, and we are thrilled to extend these benefits to our commercial customers,” said Ty Schell, CEO of Wash Patrol. “By offering these programs to businesses, we are ensuring that commercial properties receive the same level of care and attention that has made our residential services so successful.”

Wash Patrol’s commitment to quality and customer satisfaction is evident in every service they provide. The expansion of the Dirt Defense Wash Programs is a testament to the company’s dedication to meeting the evolving needs of its clients. By offering these programs to commercial customers, Wash Patrol is setting a new standard in the industry, emphasizing the importance of regular maintenance for the longevity and aesthetic appeal of commercial properties.

Businesses interested in learning more about the Dirt Defense Wash Programs can explore the comprehensive range of services offered by Wash Patrol. With a focus on delivering exceptional results, Wash Patrol continues to lead the way in pressure washing and exterior maintenance, ensuring that properties across America remain in top condition all year long.

About Wash Patrol

Wash Patrol is America’s first choice for residential pressure washing and commercial power washing services. We offer professional high-quality pressure washing services to keep the exterior of your property maintained all year long.

Media Contact
Company Name: Wash Patrol
Contact Person: Ty Schell
Email: Send Email
Phone: (833) 630-9274
City: Phoenix
State: Arizona
Country: United States
Website: https://washpatrol.com/

Keith Zralka, Owner of Zpar International, a Leader in Custom-engineered Paint, Spray and Powder Booths, Batch Ovens and Finishing Systems Moves Corporate Office to Aledo, Texas and Expands Sales Team

Keith Zralka, Owner of Zpar International, a Leader in Custom-engineered Paint, Spray and Powder Booths, Batch Ovens and Finishing Systems Moves Corporate Office to Aledo, Texas and Expands Sales Team

“The move to Aledo strengthens our ability to offer timely and dependable support to our expanding clientele in the region,” said Keith Zralka, owner of Zpar International.
Zpar International has relocated its corporate office to Aledo, Texas, to strengthen its presence in key markets and enhance client-focused service across the United States. This strategic move includes the addition of two new sales team members in Texas, allowing Zpar to provide responsive, localized expertise while continuing to deliver high-quality custom-engineered finishing systems across industries.

Zpar International, a trusted provider of custom-engineered paint booths and finishing systems, announces the relocation of its corporate office to Aledo, Texas. This strategic move aims to bring Zpar’s corporate operations closer to key markets in Texas, reinforcing the company’s commitment to responsive, client-focused service across the United States.

The transition also includes the addition of two new sales team members in Texas, enhancing Zpar’s capacity to serve its growing customer base with dedicated local expertise. While the corporate office relocation to Aledo marks a significant step in Zpar’s growth, the company remains committed to its high standards of innovation and service.

Zpar continues to deliver high-quality finishing solutions — paint booths, spray booths, powder booths, abrasive blast booths, and batch ovens — across various industries, from automotive to aerospace, meeting strict safety and performance standards.

“The move to Aledo strengthens our ability to offer timely and dependable support to our expanding clientele in the region,” said Keith Zralka, owner of Zpar International. “This new office allows us to provide responsive service and strategic guidance for our clients. With the addition of two new salespeople in Texas, we’re well-positioned to deepen our relationships and extend our presence in this key market,” added Keith Zralka.

Zpar’s Aledo location will also support the company’s comprehensive maintenance and service offerings, ensuring that clients’ systems remain operationally efficient and safe. With a focus on long-term, high-performance solutions, Zpar continues to be a trusted partner for businesses seeking reliable, custom-engineered finishing systems.

About Zpar International:

Zpar International is a leader in the design and support of custom paint booths, spray booths, powder booths, batch ovens, and abrasive blast booths. Renowned for its commitment to safety, quality, and client satisfaction, Zpar serves diverse industries with solutions that meet regulatory standards and enhance operational efficiency. Each project includes end-to-end support — from consultation and design to installation and ongoing customer care, ensuring clients receive reliable systems tailored to their unique needs.

For more information on Zpar’s new corporate office in Aledo, Texas, please contact:

Keith Zralka

Zpar International

Phone: 817-841-9425

Email: keith@zparint.com

Media Contact
Company Name: Zpar International
Contact Person: Keith Zralka
Email: Send Email
Phone: 817-841-9425
City: Aledo
State: Texas
Country: United States
Website: https://www.zparint.com/

My Irie Escape Launches Redesigned Website to Enhance Luxury Travel Experiences in Treasure Beach, Jamaica

Jamaican-Owned Vacation Property Management Company Showcases Premium Accommodations and Community Tourism.

My Irie Escape, a Jamaican-owned vacation property management company in Treasure Beach, Jamaica, is proud to announce the launch of its newly redesigned website, www.myirieescape.com. The revamped site offers travelers an immersive experience, highlighting premium accommodations and promoting the unique community-centric tourism that Treasure Beach is renowned for.

The new website reflects My Irie Escape’s dedication to providing exceptional service and connecting travelers with the authentic charm of Jamaica’s South Coast. With enhanced navigation and detailed property listings, visitors can easily explore and book luxurious accommodations that align with their preferences.

Treasure Beach is celebrated as a model for community tourism, where visitors are welcomed into a close-knit community that values sustainability, culture, and genuine hospitality. My Irie Escape plays a pivotal role in promoting this ethos by offering properties that not only provide comfort and luxury but also embody the spirit of the local community.

Among the premium properties managed by My Irie Escape are Amelia’s, a serene haven that blends modern amenities with Caribbean charm; Minerva House, ideal for families or groups seeking spacious living with breathtaking ocean views; Destiny Villa, a luxurious five-bedroom beachfront property featuring two pools and direct beach access; Hawksbill Villa, a sophisticated retreat boasting an infinity pool and panoramic coastal vistas; and Taino Cove Resort, a boutique beachfront resort offering an intimate setting for relaxation and adventure. Each property is thoughtfully designed to provide guests with an unparalleled vacation experience.

“As a Jamaican-owned company, we take immense pride in sharing the vibrant culture and unmatched beauty of Treasure Beach,” said Loraine Graveney, Founder of My Irie Escape. “Our newly redesigned website is a reflection of our dedication to delivering exceptional service and promoting premium accommodations that honor the essence of Jamaica’s beautiful South Coast.”

“My Irie Escape offers an unparalleled vacation planning experience in Jamaica, perfectly blending luxury, adventure, and deep community knowledge,” said satisfied customer Kirth Bobb. “From the moment you begin planning with them, their attention to detail and dedication to understanding your unique preferences is evident. They cater to both the refined traveler seeking relaxation and the adventurous spirit craving excitement, tailoring each itinerary with precision and care.”

The redesigned website not only enhances the booking process but also serves as a gateway to discovering the rich cultural experiences available in Treasure Beach. Travelers can access personalized itineraries, concierge recommendations, and immerse themselves in the beauty of the South Coast, all from the convenience of their devices.

To celebrate the website launch, My Irie Escape is offering special promotions and exclusive rates for bookings made through the new website for a limited time only.

For more information visit www.myirieescape.com today.

About My Irie Escape

My Irie Escape is a Jamaican-owned vacation property management company based in Treasure Beach, Jamaica. Committed to delivering exceptional service, My Irie Escape connects travelers with premium accommodations and authentic cultural experiences. By promoting properties that embody the essence of Jamaica’s South Coast, the company plays a vital role in supporting community tourism and sustainability initiatives in the region.

Media Contact
Company Name: My Irie Escape
Contact Person: Loraine Graveney
Email: Send Email
Phone: 876.471.1099
Country: Jamaica
Website: https://www.myirieescape.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: My Irie Escape Launches Redesigned Website to Enhance Luxury Travel Experiences in Treasure Beach, Jamaica

Airway Management Devices Market is projected to register an impressive CAGR, Revenue, and Prominent Players by 2028

“The airway management devices industry is expected to experience significant growth over the next few years. This is due to the increasing demand for advanced medical devices that help to manage a patient’s airway during medical procedures.”
Browse 235 market data Tables and 43 Figures spread through 295 Pages and in-depth TOC on “Airway Management Devices Market by type (Endotracheal tubes, Tracheostomy tube, Oropharyngeal, Nasopharyngeal, Laryngoscopes, Resuscitators), Application (Anesthesia, Emergency medicine), End user (Hospitals, Home care settings)- Global Forecast to 2028

Airway Management Devices Market in terms of revenue was estimated to be worth $1.8 billion in 2022 and is poised to reach $2.4 billion by 2028, growing at a CAGR of 5.6% from 2022 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by increasing prevalence of respiratory tract infections and chronic respiratory diseases. Moreover, increasing number of emergency care admission and favourable reimbursement coverage across emerging countries supporting the growth of airway management devices market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116806061

Laryngoscopes segment is expected to account for the second largest share in 2022. 

Laryngoscopy is a medical procedure that provides a full view of the vocal folds and the glottis using a laryngoscope. Increasing demand of laryngoscopes are attributed to the rising burden of respiratory complications due to increasing pollution and growing need for intubation and chronic respiratory disease prevalence is expected to drive the airway management devices market.

The anesthesia segment held the largest market share in the airway management devices market by application

By application, the anesthesia segment accounted for the largest share in 2022. Airway management devices are widely used in anesthesia for maintaining unobstructed breathing during and after the surgical procedure. Increasing number in surgical procedures and demand for maintaining a safe breathing passage to lower the risk of anesthesia-related complications during surgery is driving the demand for airway management devices in the anesthesia segment.

The pediatric patient segment is expected to grow at the highest rate during the forecast period

The pediatric/neonatal patients’ segment is expected to show rapid growth in the patient age segment during the forecast period.  Factors attributing to the growth of the segment is due to the rising number of pre-term births and the rising healthcare expenditure and the improving healthcare infrastructure in countries are contributing to the rapidly increasing demand for infant/neonatal airway management devices.

Hospitals dominates the global airway management devices market during the forecast period

Based on end-user the hospital segment accounted for the largest market share during the forecast period. The large share of this segment can be attributed to the increasing number of hospitals and economic & infrastructural development, especially in developing countries. Moreover, the increasing surgical procedures performed across emerging rooms where airway management devices are used also supports growth in the hospitals segment.

Asia Pacific is expected to account for the highest CAGR in the airway management devices market

The Asia Pacific airway management devices market is expected to grow at the highest CAGR during the forecast period. Asia Pacific is driven by rising number of geriatric populations, increasing demand for critical care units and the low infrastructure and treatment costs and the presence of highly educated physicians have driven medical tourists to APAC countries, particularly to Malaysia, India, and China.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=116806061

Airway Management Devices Market Dynamics:

Drivers:

  1. Increasing prevalence of chronic respiratory diseases
  2. Growing demand for emergency and intensive care
  3. Growing incidence of pre-term births globally
  4. Government support for improving emergency care infrastructure

Restraints:

  1. Lack of reimbursement policies across developing countries

Opportunities:

  1. Growing demand for single-use airway management devices
  2. Increased growth potential in emerging countries

Challenges:

  1. Harmful effects of airway management devices on neonatal patients
  2. Dearth of skilled professionals for airway management procedures
  3. Increasing pricing pressure on key market players

Key Market Players:

The airway management devices market is dominated by players such Medtronic (Ireland), ICU Medical, Inc. (US), Teleflex Incorporated (US), Ambu A/S (Denmark), ConvaTec Group Plc (UK).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=116806061

Airway Management Devices Market Advantages:

  • Provides a detailed analysis of the current and emerging Airway Management Devices market trends and dynamics.
  • Offers an in-depth analysis of the market size in terms of volume and value.
  • In-depth analysis of the key segments of the Airway Management Devices market.
  • Comprehensive analysis of the factors that drive and restrain the growth of the market.
  • Comprehensive analysis of the regional markets for Airway Management Devices.
  • Comprehensive analysis of the competitive landscape and detailed profiles of the major players in the market.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/airway-management-device-market-116806061.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Airway Management Devices Market is projected to register an impressive CAGR, Revenue, and Prominent Players by 2028